Premium
Drug‐coated balloons: “Do they still have a role in treating coronary artery disease?”
Author(s) -
Shatila Wassim,
Krajcer Zvonimir
Publication year - 2017
Publication title -
catheterization and cardiovascular interventions
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.988
H-Index - 116
eISSN - 1522-726X
pISSN - 1522-1946
DOI - 10.1002/ccd.27307
Subject(s) - medicine , restenosis , coronary artery disease , cad , balloon , cardiology , drug , angioplasty , stent , pharmacology , engineering drawing , engineering
Key Points Small vessels with coronary artery disease (CAD) are at high risk of restenosis, despite the use of drug‐eluting stents (DESs). Drug‐coated balloon (DCB) therapy offers a viable alternative to DESs for the management of small vessel CAD. The literature regarding the use of DCBs in lieu of the newer generation DESs to treat small vessel CAD is controversial.